XEN Cell Culture Medium Composition for Consistent Proliferation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing culture conditions for extraembryonic endoderm stem cells (XEN cells) are inefficient and lead to variations among cell lines and limited proliferative ability, particularly in serum-free media.

Innovation Solution

A medium composition optimized for XEN cell culture, comprising a fibroblast growth factor, a leukemia inhibitory factor, a WNT signaling activator (such as CHIR99021), and a B27 supplement, which promotes consistent and efficient maintenance of XEN cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If serum-containing media (FBS) is used for XEN cell culture, then cell proliferation is maintained, but batch variations and heterogeneous cell populations occur

Engineering Contradiction:
Improvecell proliferationVSAvoidbatch consistency
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention transitions from serum-containing media to serum-free media, fundamentally changing the cultural parameter. This replacement eliminates the batch variation inherent in fetal bovine serum while maintaining cell proliferation through carefully controlled growth factors and signaling molecules, thus resolving the contradiction between productivity and reliability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention extracts and removes the serum component from the culture medium, eliminating the source of batch variations and heterogeneity. By taking out the problematic serum and replacing it with a defined composition of growth factors, the invention achieves both consistent results and maintained proliferation

Inventive Principle:
Principle #2Taking out (Extraction)

2Reliability

If serum-free media (KSR-based) with FGF4 is used, then batch consistency is improved, but cell senescence occurs

Engineering Contradiction:
Improvebatch consistencyVSAvoidcell proliferative ability
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The invention modifies the serum-free media composition by adding specific growth factors (FGF2, LIF, Activin A) and signaling molecules (CHIR99021, IWP2) to the KSR-based medium. This parameter change restores and enhances cell proliferative ability while maintaining the batch consistency advantage of serum-free media, preventing cell senescence

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a composite culture medium that combines KSR (for batch consistency) with multiple growth factors and signaling molecules (for preventing senescence). This composite formulation synergistically integrates the advantages of serum-free consistency with the proliferative support needed to prevent cell aging

Inventive Principle:
Principle #40Composite materials

3Reliability

If N2B27-based medium with FGF2 and LIF is used, then batch consistency is improved, but doubling time is prolonged

Engineering Contradiction:
Improvebatch consistencyVSAvoidcell proliferation rate
Core Design Contradiction:
ReliabilityVSSpeed

Solution Approach 1:

The invention changes the media composition by supplementing N2B27 with additional growth factors (FGF4, Activin A) and signaling molecules (CHIR99021, IWP2). This parameter optimization accelerates the proliferation rate while maintaining the batch consistency benefit of the defined media formulation

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20250129331A1Medium composition for culture of extraembryonic endoderm stem cells
Publication Date: 2025.04.24 SPACE F CORP
  • US20250129331A1 patent drawing
  • US20250129331A1 patent drawing
  • US20250129331A1 patent drawing

AI summary

The present invention relates to a medium composition for culture of extraembryonic endoderm stem cells, and more specifically, to a medium composition for in vitro culture of extraembryonic endoderm stem cells.